ALCAM and cancer: This may provide a clue as to the differential in vitro and clinical impact of ALCAM in our study, and may suggest that loss of ALCAM may influence cellular traits but may also regulate the expression/phosphorylation of receptors and/or signaling pathways such as MET, a pathway frequently dysregulated in cancer [39], and/or other downstream effector pathways.